| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |